Bangkok Genomics Innovation Public Company LimitedSET: BKGI🇹🇭 TH

CG Structure · 2024

Board Composition

Total Number of Directors

11

Male Directors

10

Female Directors

1

Independent Directors

4

Non-executive Directors

9

Non-executive Directors Who Are Not Independent

5

Executive Directors

2

Total Board Meetings Held

5

Board of Directors

Directors

TitleFirst NameLast NameGenderYear of BirthNationalityResident in Thailand?PositionExecutive or Non-executiveIndependent Director?Director TypeAppointment DateAuthorised to Sign?Related to Another Director or Executive?Any Legal Violation in the Past 5 Years?Highest EducationField of StudySkills & ExpertiseDirector TrainingAttended Director Training?Director Accreditation Program (DAP)?Director Certification Program (DCP)?Board Meetings HeldBoard Meetings AttendedAGMs HeldAGMs AttendedMeeting Allowance (Baht)Other Remuneration (Baht)Total Remuneration (Baht)Remuneration from Subsidiaries (Baht)Non-monetary RemunerationShares HeldShareholding (%)
Mr.THOSAPORNSIRISUMPHANDM1,960643 · Description: ThailandYChairman of the boardNon-executiveYContinuing director (Full term of directorship and being re-appointed as a director)2022-01-28T00:00NNNDoctoral degreePolitical Science1683 · Description: Business Administration · 158 · Description: Corporate Management · 3173 · Description: Public AdministrationNNY55110600,000600,00000300,0000.05
Mr.PREECHALAOHAPONGCHANAM1,954643 · Description: ThailandYDirectorNon-executiveNExisting director2017-09-11T00:00YNNMaster's degreeLaw1683 · Description: Business Administration · 141 · Description: Law · 133 · Description: CommerceNYN55110480,000480,0000073,638,00012.27
Mr.GOANPOTASVINVICHITM1,956643 · Description: ThailandYDirectorNon-executiveNExisting director2020-06-25T00:00YNNMaster's degreeBusiness Administration1683 · Description: Business Administration · 112 · Description: Economics · 118 · Description: BankingNYY55110480,000480,00000100,0000.02
Mr.NINGLIM1,981479 · Description: ChinaNDirectorNon-executiveNContinuing director (Full term of directorship and being re-appointed as a director)2020-06-25T00:00YNNDoctoral degreeScience134 · Description: Health Care ServicesNYN51100480,000480,00000
Mr.SUJIECAOM1,986479 · Description: ChinaNDirectorNon-executiveNContinuing director (Full term of directorship and being re-appointed as a director)2020-06-25T00:00YNNBachelor's degreeScience134 · Description: Health Care ServicesNYN55110480,000480,000002,450,0000.41
Mr.ZONGZEWUM1,983479 · Description: ChinaNDirectorNon-executiveNExisting director2022-01-28T00:00YNNDoctoral degreeScience134 · Description: Health Care ServicesNYN52110480,000480,00000
Ms.SAOWALAKDANSAKULF1,979643 · Description: ThailandYDirectorExecutiveExisting director2022-01-28T00:00YNNDoctoral degreeScience134 · Description: Health Care Services · 113 · Description: Agribusiness1731 · Year: 2024 · Description: Director Certification Program (DCP) · 1738 · Year: 2024 · Description: Subsidiary Governance Program (SGP) · 2024 · Description: Arbitration Procedure Training Program · 2024 · Description: Cybersecurity Leadership Certificate Program for Business · 2024 · Description: Medical Leadership Certificate, Class 1YYY5511000002,000,0000.33
Mr.XIAOHANWANGM1,990479 · Description: ChinaNDirectorExecutiveExisting director2022-01-28T00:00YNNBachelor's degreeScience1683 · Description: Business Administration · 134 · Description: Health Care ServicesNYN5511000002,250,0000.38
Mr.VICHATETANTIWANICHM1,961643 · Description: ThailandYDirectorNon-executiveYExisting director2022-01-28T00:00NNNMaster's degreeBusiness Administration165 · Description: Risk Management · 166 · Description: Audit · 1683 · Description: Business Administration · 112 · Description: Economics · 150 · Description: IT ManagementNNY55110480,000480,0000052,6000.01
Mr.VICHYAKREANGAMM1,981643 · Description: ThailandYDirectorNon-executiveYContinuing director (Full term of directorship and being re-appointed as a director)2022-01-28T00:00NNNDoctoral degreeLaw141 · Description: LawNYN55110480,000480,00000
Mr.JEDSADACHOKDAMRONGSUKM1,958643 · Description: ThailandYDirectorNon-executiveYExisting director2023-06-22T00:00NNNBachelor's degreeMedicine134 · Description: Health Care ServicesNNY55100480,000480,00000

Board Meetings & Remuneration

Date of the Annual General Meeting

2024-02-29T00:00

Was an Extraordinary General Meeting Held?

No

Board Meeting Allowance (Baht)

0.0

Other Board Remuneration (Baht)

4440000.0

Total Board Remuneration (Baht)

4440000.0

Balance of Power Between the Board and Management

Are There Measures Balancing the Board's and Management's Power?

Yes

Measures Balancing the Board's and Management's Power

The Company has appointed four independent directors, accounting for 36.36% of the total 11 directors, and nine non-executive directors, representing 81.82% of the total board members. This composition ensures a balance of power between executive directors and management. Regarding the board meeting agenda setting, an independent director or the chairman, who is also an independent director, must be involved in the agenda-setting process. If the chairman is unable to attend or participate in setting the agenda, the chairman of the audit committee or an appointed representative acting as the meeting chairman will be responsible for determining the agenda. Additionally, those involved in the agenda-setting process must not be executive directors.

Methods Used to Balance Power

Method
Appointment of an independent director Participate in determining the meeting agenda for the committee

Board Roles, Duties and Charter

Does the Company Have a Board Charter?

Yes

Content of the Board Charter

Scope of Authority, Duties, and Responsibilities of the Board of Directors are as follows;

1. Define the objectives, key business goals, vision, mission, policies, strategies, business plans, organizational structure, approval authority, and budget of the Company. Supervise the allocation of key resources and review, examine, and approve the Company's policies, strategies, business plans, and operational direction, including those of its subsidiaries, as proposed by the management.

2. Monitor and supervise the Company's performance, management, and operations, ensuring alignment with the Company’s objectives, vision, mission, strategies, business plans, and budget to maximize value for the Company and its shareholders effectively and efficiently.

3. Oversee the Company’s management and operations to ensure compliance with its policies, corporate governance principles, securities laws, and related regulations issued by the Securities and Exchange Commission (SEC) and the Stock Exchange of Thailand (SET), including related-party transactions and significant asset acquisitions or disposals, provided that they do not conflict with other laws.

4. Establish a comprehensive risk management policy covering the entire organization and oversee the implementation of appropriate risk management systems and control measures to mitigate business risks effectively.

5. Ensure the implementation of an appropriate and effective accounting system, including an internal control system and internal audit process, and conduct regular assessments of the adequacy of the Company's internal control system.

6. Define the management structure, including the authority to appoint subcommittees, the Chief Executive Officer (CEO), and other committees as deemed appropriate. The delegation of authority must not allow subcommittees, the CEO, or other committees to approve transactions that may involve conflicts of interest unless they comply with the policies and criteria previously approved by the Board.

7. Establish corporate governance policies in written form, ensure their effective implementation, and promote ethical business practices that respect the rights of shareholders and stakeholders, contributing positively to society and the environment while maintaining adaptability to changing business conditions.

8. Manage and address conflicts of interest among stakeholders, including preventing the misuse of the Company's assets, information, and opportunities, as well as improper transactions with related parties. Any director with a personal interest in a transaction involving the Company or a change in shareholding proportion must immediately notify the Company.

9. The Board may delegate authority to one or more directors or other individuals to act on its behalf under the Board’s supervision. The Board may revoke, withdraw, modify, or amend such delegation of authority as necessary. However, such delegation must not permit decision-making or approvals of transactions where the delegate has a conflict of interest, personal gain, or other conflicting interests with the Company, as defined by the Capital Market Supervisory Board and/or SET regulations, unless the transactions comply with the policies and guidelines previously approved by the Board.

Other Board Governance Matters

Board Governance Practices

PracticeYes / No
The chairman of the board and the highest-ranking executive are from the same personN
The chairman of the board is an independent directorY
The chairman of the board and the highest-ranking executive are from the same familyN
Chairman is a member of the executive board or taskforceN
The company appoints at least one independent director to determine the agenda of the board of directors’ meetingY

Audit Committee

Audit Committee Charter

Roles, Duties and ResponsibilitiesType of Subcommittee
1. Review the Company's financial reports to ensure accuracy and adequate disclosure. 2. Review the Company's internal control system and internal audit system for appropriateness and effectiveness, as well as assess the independence of the internal audit function. This includes approving the appointment, transfer, dismissal, and remuneration of the head of internal audit or any other department responsible for internal audit. 3. Review the Company's risk management policies and implementation to ensure compliance with established guidelines. 4. Ensure the Company's compliance with securities and exchange laws, stock exchange regulations, and other applicable business laws. 5. Evaluate, select, and propose the appointment of an independent auditor and determine their remuneration. Additionally, hold at least one meeting per year with the external auditor without management participation. 6. Review related-party transactions and potential conflict of interest transactions to ensure compliance with securities laws and stock exchange regulations, ensuring that such transactions are reasonable and in the best interest of the Company. 7. Prepare and disclose an Audit Committee Report in the Annual Report, signed by the Chairman of the Audit Committee, including at least the following: 7.1) Opinion on the accuracy, completeness, and reliability of the Company's financial reports. 7.2) Opinion on the adequacy of the internal control system. 7.3) Opinion on compliance with securities laws, stock exchange regulations, and other applicable business laws. 7.4) Opinion on the appropriateness of the external auditor. 7.5) Opinion on transactions that may involve conflicts of interest. 7.6) Number of Audit Committee meetings and attendance records of each committee member. 7.7) Overall observations and recommendations based on duties performed under the Audit Committee Charter. 8. Report any other matters that shareholders and investors should be aware of, within the scope of duties assigned by the Board of Directors, including reviewing and approving the Company's internal audit plan and evaluating the performance of the internal control auditor. 9. The Audit Committee has the authority to seek independent professional opinions when necessary, at the Company's expense. 10. Ensure the Company complies with corporate governance, social responsibility, and anti-corruption policies, including handling fraud and corruption complaints from internal personnel, conducting investigations, and submitting cases to the Board of Directors for disciplinary action and resolution. 11. If the Audit Committee identifies or suspects any of the following issues that may significantly impact the Company's financial position and performance, it must report to the Board of Directors for timely corrective action: 11.1) Transactions that may involve conflicts of interest. 11.2) Fraud, irregularities, or significant deficiencies in internal control systems. 11.3) Violations of securities laws, stock exchange regulations, or other applicable business laws. 12. Perform any other duties assigned by the Board of Directors.
3091 · Description: Audit of financial statements and internal controls · 3092 · Description: Risk management

Audit Committee Members

TitleFirst NameLast NamePositionGenderYear of BirthNationalityResident in Thailand?Appointment DateHighest EducationField of StudyHas Accounting or Financial Expertise?Skills & ExpertiseMeetings HeldMeetings AttendedMeeting Allowance (Baht)Other Remuneration (Baht)Total Remuneration (Baht)Remuneration from Subsidiaries (Baht)Non-monetary Remuneration
Mr.VICHATETANTIWANICHChairman of the audit committeeM1,961643 · Description: ThailandY2022-01-28T00:00Master's degreeBusiness AdministrationY165 · Description: Risk Management · 166 · Description: Audit · 1683 · Description: Business Administration · 112 · Description: Economics · 150 · Description: IT Management4480,000080,00000
Mr.VICHYAKREANGAMAudit committeeM1,981643 · Description: ThailandY2022-01-28T00:00Doctoral degreeLawN141 · Description: Law4460,000060,00000
Mr.JEDSADACHOKDAMRONGSUKAudit committeeM1,958643 · Description: ThailandY2023-06-22T00:00Bachelor's degreeMedicineN134 · Description: Health Care Services4460,000060,00000

Audit Committee — Meeting Allowance (Baht)

200000.0

Audit Committee — Other Remuneration (Baht)

0.0

Audit Committee — Total Remuneration (Baht)

200000.0

Executive Committee

Executive Committee Charter

Roles, Duties and ResponsibilitiesType of Subcommittee
1. Conduct and manage the Company’s operations in accordance with its objectives, articles of association, policies, regulations, resolutions of the Board of Directors and/or shareholder meetings, within the framework of applicable laws. 2. Review and evaluate management proposals regarding organizational structure, vision, mission, goals, policies, business strategies, operational plans, investment expansion, financial planning, annual report, budget allocation, human resource management, and IT investments, before submitting them for Board approval. 3. Appoint working committees for specific tasks, define their roles, responsibilities, and authority, and oversee their performance to ensure alignment with the Company’s policies and goals. 4. Provide guidance, advice, and policy direction to the Chief Executive Officer (CEO) and special task forces. 5. Monitor the performance of the Company and its subsidiaries to ensure operations are aligned with approved policies and objectives, maintaining quality and efficiency. 6. Review and approve the annual budget allocation proposed by management before submission to the Board of Directors for approval. 7. Approve financial expenditures for regular business transactions, provided they do not exceed the budget approved by the Board. 8. Assess feasibility and approve participation in new projects, bids, and contracts, ensuring compliance with legal and stock exchange regulations. 9. Approve significant capital expenditures as outlined in the Company’s annual budget, as delegated by the Board. 10. Authorize loan transactions, banking and financial operations, including account openings, loan applications, intra-group financing, and credit facilities, within the approved limits. Any exceeding amounts must be submitted to the Board for review in the next meeting. If assets are used as collateral, prior Board approval is required. 11. Monitor the Company’s financial performance and propose dividend payments to the Board for approval. 12. Establish the Company’s organizational structure, management authority, hiring, promotion, transfer, termination, and compensation policies for executives at the director level or equivalent, excluding the CEO. 13. Delegate authority to individuals or committees to conduct Company operations, ensuring oversight and compliance with governance principles. This authority can be revoked, amended, or modified as deemed necessary. 14. Appoint advisory committees and consultants, including determining remuneration, allowances, benefits, and other related expenses. 15. Appoint executive positions within the Company, except for the CEO, which requires Board approval. 16. Convene Executive Committee meetings and set meeting regulations as deemed necessary. 17. Approve operational authority for executives in line with Company rules and regulations. 18. Ensure the Company maintains an effective internal control system, coordinating with the Audit Committee. 19. Nominate qualified candidates for director and executive positions in subsidiaries and affiliates, ensuring governance compliance before seeking Board approval. 20. Perform any other duties assigned by the Board of Directors. Authority Limitations The delegation of authority to the Executive Committee shall not include approval for transactions where members have conflicts of interest, personal gains, or related party transactions, as defined by the Securities and Exchange Commission (SEC), Stock Exchange of Thailand (SET), and other relevant regulators. Such matters must be presented to the Board or shareholders for approval, except for transactions conducted under normal business operations and standard commercial terms as defined by the SEC, SET, or other relevant authorities.
3093 · Description: Director and executive nomination · 3094 · Description: Remuneration · 3096 · Description: Sustainability development

Executive Committee Members

TitleFirst NameLast NamePositionGenderYear of BirthNationalityResident in Thailand?Appointment DateHighest EducationField of StudyMeetings HeldMeetings AttendedMeeting Allowance (Baht)Other Remuneration (Baht)Total Remuneration (Baht)Remuneration from Subsidiaries (Baht)Non-monetary Remuneration
Mr.GOANPOTASVINVICHITChairman of the executive committeeM1,956643 · Description: ThailandY2022-01-28T00:00Master's degreeBusiness Administration4480,000080,00000
Mr.PREECHALAOHAPONGCHANAMember of the executive committeeM1,954643 · Description: ThailandY2022-01-28T00:00Master's degreeLaw4460,000060,00000
Mr.SUJIECAOMember of the executive committeeM1,986479 · Description: ChinaN2022-01-28T00:00Bachelor's degreeScience4460,000060,00000
Ms.SAOWALAKDANSAKULMember of the executive committeeF1,979643 · Description: ThailandY2022-01-28T00:00Doctoral degreeScience4400000
Mr.XIAOHANWANGMember of the executive committeeM1,990479 · Description: ChinaN2022-01-28T00:00Bachelor's degreeScience4400000

Executive Committee — Meeting Allowance (Baht)

200000.0

Executive Committee — Other Remuneration (Baht)

0.0

Executive Committee — Total Remuneration (Baht)

200000.0

Executives

Executives

TitleFirst NameLast NamePositionGenderYear of BirthNationalityResident in Thailand?Appointment DateHighest EducationField of StudyField of Study — Please SpecifySkills & ExpertiseIs the Highest-ranking Executive?Is the Highest-ranking Accounting or Finance Officer?Directly Responsible for Accounting?Appointed After the End of the Fiscal Year?
Ms.SAOWALAKDANSAKULCHIEF EXECUTIVE OFFICERF1,979643 · Description: ThailandY2022-01-28T00:00Doctoral degreeScience134 · Description: Health Care Services · 113 · Description: AgribusinessYNNN
Mr.XIAOHANWANGDeputy Chief Executive OfficerM1,990479 · Description: ChinaN2019-10-01T00:00Bachelor's degreeScience1683 · Description: Business Administration · 134 · Description: Health Care ServicesNNNN
Mr.KittikunRodrangnokChief Financial OfficerM1,990643 · Description: ThailandY2021-09-23T00:00Bachelor's degreeAccounting143 · Description: AccountingNYYN
Mr.PorntepTanyutChief Operating OfficerM1,986643 · Description: ThailandY2024-01-03T00:00Master's degreeotherDepartment of Immunology134 · Description: Health Care ServicesNNNN
Mr.SiriyodDenmongkholchaiLaboratory DirectorM1,989643 · Description: ThailandY2023-12-21T00:00Doctoral degreeotherDepartment of Medical Microbiology (Interdisciplinary)134 · Description: Health Care ServicesNNNN

Executive Remuneration

Monetary Remuneration

MetricCurrent YearPrevious YearTwo Years Ago
Total remuneration of executive directors and executives (baht)9,432,47410,875,574.468,751,665.17
Total remuneration of executive directors (baht)
Total remuneration of executives (baht)

Other Remuneration

MetricCurrent YearPrevious YearTwo Years Ago
Company’s contribution to provident fund for executive directors and executives (Baht)395,090349,000124,000
Employee Stock Ownership Plan (ESOP)000
Employee Joint Investment Program (EJIP)000

Remuneration or Benefits Payable to Executives

MetricAmount (Baht)
Outstanding remuneration or benefits of executive directors and executives in the past year (baht)432,000
Estimated remuneration of executive directors and executives in the current year (baht)

Remuneration Policy

Executive Remuneration Policy

The Company recognizes the significance of the roles, duties, and responsibilities of the Board of Directors, Audit Committee, Executive Committee, and senior management, as they are key figures in driving the business towards its objectives, goals, and sustainable growth. Therefore, the Company carefully considers the structure and remuneration levels for directors to ensure they are appropriate to their responsibilities and serve as an incentive for the Board to lead the organization toward both short-term and long-term success. The remuneration of directors must align with the Company’s long-term strategies and goals, their experience, duties, scope of roles and responsibilities, and the expected contributions of each director. The remuneration structure is designed to be comparable to industry standards while being subject to shareholder approval, ensuring that compensation remains reasonable and not excessive. The following criteria are used to determine director and executive compensation:


1. Evaluate and establish appropriate compensation structures and criteria for the remuneration of the Board of Directors, Chief Executive Officer (CEO), and Deputy Chief Executive Officer (Deputy CEO) to ensure fairness and suitability.

2. Determine performance evaluation criteria for the CEO and Deputy CEO, which will be submitted to the Board of Directors for approval.

3. Set annual or quarterly remuneration for directors, the CEO, and the Deputy CEO, considering the CEO’s performance evaluation results, and include this matter in the Board meeting agenda for approval.

4. Review conditions and details of new securities offerings or stock options for directors and employees, if applicable.

5. Ensure director compensation is competitive within the industry, reflecting their experience, responsibilities, and expected contributions. Directors with additional roles, such as serving on subcommittees, should receive appropriate additional compensation.

6. Ensure compensation for the CEO, Deputy CEO, and senior executives follows the policies set by the Board within the approved framework from the shareholders' meeting. The salary, bonuses, and long-term incentives should align with the Company’s performance and the individual performance of each executive, ensuring the best interests of the Company.

Was an Opinion Obtained from the Board and the Remuneration Committee?

No

Employees

Any Significant Change in Headcount in the Past 3 Years?

Yes

Significant Changes in Headcount

Currently, the labor market is highly competitive, leading companies to attract skilled personnel with more appealing offers, including compensation, benefits, and career advancement opportunities. These factors are the primary reasons why companies are facing increased employee turnover rates, which significantly impacts the number of employees.

Provident Fund

Does the Company Have a Provident Fund?

Yes

Provident Fund Policy

The company has established a provident fund as a guarantee of security and to motivate employees, managed by SCB Asset Management Company Limited under the name "SCB Provident Fund Master Fund," which is registered with the Securities and Exchange Commission (SEC). The company selects the fund based on its past performance and the fees associated with fund management.

Auditors and Audit Fees

How Audit Fees Are Reported

SEPERATE

Company Auditor and Fees

Audit FirmSub-districtDistrictProvincePostcodeAuditorsAudit Fee (Baht)Any Non-audit Fee?
DR. VIRACH AND ASSOCIATES COMPANY LIMITEDWAT THA PHRABANGKOK YAIBangkok10600virach_asso@vaaudit.com · Title: 260 · Regis no: 3196 · Last name: AUNPITIPONGSA · First name: CHAIYAKORN1,610,000N

How Subsidiary Audit Information Is Reported

AUDITOR_AND_FEE

Subsidiary Auditors and Fees

Audit FirmSub-districtDistrictProvincePostcodeAuditorsAudit Fee (Baht)Any Non-audit Fee?
DR. VIRACH AND ASSOCIATES COMPANY LIMITEDWAT THA PHRABANGKOK YAIBangkok10600virach_asso@vaaudit.com · Title: 260 · Regis no: 3196 · Last name: AUNPITIPONGSA · First name: CHAIYAKORN45,000N

Company Secretary and Other Assigned Persons

Company Secretary

TitleFirst NameLast NameEmailTelephone
Ms.NuttineeKittisorayutnuttinee@bangkokgenomics.com062-1588783

Chief Accountant

TitleFirst NameLast NameEmail
Mr.KittikunRodrangnokkittikun@bangkokgenomics.com

Head of Internal Audit

TitleFirst NameLast NameEmail
Ms.WanvimolJongsureeyapaswanvimol.jo@plgroup.co.th

Investor Relations Contact

Does the Company Have an Investor Relations Contact?

Yes

Investor Relations Contacts

TitleFirst NameLast NameEmailTelephone
Mr.KittikunRodrangnokkittikun@bangkokgenomics.com063-0211580

Representatives in Thailand (Foreign Companies)

Does the Company Have Representatives in Thailand?

No

Contents